| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/02/2002 | CN1329589A N-aralkylaminotetralins as ligands for neuroptide YY5 receptor |
| 01/02/2002 | CN1328998A Preparation method of 3-oxyindole derivative for synthesizing indigo |
| 01/02/2002 | CN1328997A Method for synthesizing indigo by using N-substituted glycine or glycine ester |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/02/2002 | CN1077109C S type 2-substituted hydroxy 2-indolidinylbutyric ester compounds and process for preparation thereof |
| 01/01/2002 | US6335463 Copper catalyzed arylation of 2,5-dichlorobenzoic acid with n-(4-fluorophenyl)glycine in which alkali metal salts are employed in aqueous alkaline environment |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335450 Efficient cyclic-bridged cyanine dyes |
| 01/01/2002 | US6335360 Indoline-2-carboxylic amide derivatives; obesity, eating and psychological disorders |
| 01/01/2002 | US6335359 Topically applying to skin or scalp to treat dermatitis or acne; side effect reduction |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335333 Matrix metalloproteinase inhibitors |
| 01/01/2002 | CA2215333C Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
| 12/27/2001 | WO2001098267A1 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
| 12/27/2001 | WO2001097787A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | WO2001097782A1 Stable gabapentin having ph within a controlled range |
| 12/27/2001 | WO2001097751A2 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/27/2001 | WO2001063345A9 Photochemically controlled photonic crystal diffraction |
| 12/27/2001 | WO2000064864A9 N-protected amines and their use as prodrugs |
| 12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
| 12/27/2001 | US20010056112 Synthetic compounds for treatment of inflammation |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | US20010056099 Method of reducing morbidity and the risk of mortality |
| 12/27/2001 | US20010056096 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
| 12/27/2001 | US20010056094 3-(Cycloalkanoheteroarylidenyl)-2-Indolinone Protein Tyrosine Kinase Inhibitors |
| 12/27/2001 | US20010055567 Uses water-soluble dyes and their biomolecule adducts, each having specific photophysical and pharmaco-chemical properties, as contrast media for fluorescence and transillumination diagnostics |
| 12/27/2001 | CA2413277A1 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | CA2412188A1 3-azabicyclo¬3.1.0|hexane derivatives useful in therapy |
| 12/27/2001 | CA2411100A1 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/26/2001 | CN1328554A Eletriptan hydrobromide monohydrate |
| 12/26/2001 | CN1328471A Near infrared fluorescent contrast agent and fluorescence imaging |
| 12/26/2001 | CN1328455A Use of N-substituted azabicycloalkane derivatives for treating diseases of central nervous system |
| 12/25/2001 | US6333339 3-Benzylpiperidine |
| 12/25/2001 | US6333323 Indole derivatives with antiviral activity |
| 12/25/2001 | CA2052424C 2-(4-piperidinyl)-1h-pyrido¬4,3-b|indol-1-ones and related compounds, intermediates and a process for their preparation |
| 12/20/2001 | WO2001096336A2 6,5-fused bicyclic heterocycles |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096300A1 Growth hormone secretagogues |
| 12/20/2001 | WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 12/20/2001 | WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | WO2001046121A3 Exciplexes |
| 12/20/2001 | WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 12/20/2001 | US20010053778 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 12/20/2001 | DE10029285A1 New 3-(anilino-methylidene)-2-indolinone derivatives, are kinase inhibitors and cell proliferation inhibitors, useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis |
| 12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | CA2412462A1 6,5-fused bicyclic heterocycles |
| 12/20/2001 | CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 12/20/2001 | CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 12/19/2001 | EP1163225A1 Compounds and methods for modulation of estrogen receptors |
| 12/19/2001 | EP1163220A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist |
| 12/19/2001 | EP1163219A1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |
| 12/19/2001 | EP0912573B1 Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents |
| 12/19/2001 | CN1327469A Organic electroluminescent element |
| 12/19/2001 | CN1327444A Alpha 1 beta-adrenergic receptor antagonists |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/19/2001 | CN1326930A Method for producing cyclic compounds |
| 12/19/2001 | CN1076348C 3-bustituted oxindole derivatives as patassium path regulating agent |
| 12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
| 12/18/2001 | US6331632 Cyanine dye phosphoramidites |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
| 12/18/2001 | US6331554 Antipicornaviral compounds, compositions containing them, and methods for their use |
| 12/18/2001 | US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 12/18/2001 | CA2031897C Carbamoyl derivatives |
| 12/13/2001 | WO2001094359A1 Chiral ligands for asymmetric catalysis |
| 12/13/2001 | WO2001094312A2 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 12/13/2001 | WO2001094311A1 Cytoprotectors |
| 12/13/2001 | WO2001094310A1 Methods for making bis-heterocyclic alkaloids |
| 12/13/2001 | WO2001068599A3 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 12/13/2001 | WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters |
| 12/13/2001 | WO2001032647A3 Benz`f!indoles for use in the treatment of 5ht receptor related disorders |
| 12/13/2001 | US20010051657 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 12/13/2001 | DE10032134C1 Compositions for oxidative dyeing of keratinic fibers, especially human hair, comprise new or known 2-hydroxy-5-amino-biphenyl derivatives as developers |
| 12/13/2001 | CA2410509A1 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 12/13/2001 | CA2410410A1 Chiral ligands for asymmetric catalysis |
| 12/12/2001 | EP1161948A2 Pharmaceutical or food composition for treatment of brain edema |
| 12/12/2001 | EP1161434A1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 12/12/2001 | EP1161422A1 Amine derivatives as protease inhibitors |
| 12/12/2001 | EP1161418A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP1161233A2 Lxr modulators |
| 12/12/2001 | EP1119546A4 Process for preparing toluenesulfinates |
| 12/12/2001 | EP0968175B1 Spiro compounds and the use thereof |
| 12/12/2001 | EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 12/12/2001 | CN1326347A 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens |
| 12/11/2001 | US6329550 For therapy of emphysema, osteoporosis, rheumatoid arthritis and neoplastic diseases |
| 12/11/2001 | US6329531 For therapy of alzheimer's disease |
| 12/11/2001 | US6329443 Acrylates and actinic radiation-curable compositions containing them |
| 12/11/2001 | US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 12/11/2001 | US6329416 Administering to female of child bearing age for 28 consecutive days: first phase dosage of progestational agent; second phase of antiprogesin compound, and third phase of placebo for contraception |
| 12/11/2001 | US6329405 As ileal bile acid transporter inhibitor, for therapy of hyperlipemia |
| 12/11/2001 | US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 12/11/2001 | US6329394 Medical use for tachykinin antagonists |
| 12/11/2001 | US6329372 Phenylalanine derivatives |
| 12/11/2001 | US6329366 Heterocyclic, piperidine, indole derivitives for treatment of nervous system disorders and serotonin antagonist |
| 12/11/2001 | US6328855 Method for producing (+)-exo-6-phenyl-3-azabicyclo-[3.2.0]heptanes |